(Q36535110)

English

Uveitis: management

scientific article published on December 14, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Uveitis: management (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

author name string

S. Lightman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683928

28 October 2022

language of work or name

0 references

publication date

1 December 1991

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

14 December 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683928

28 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:014067369192310X?httpAccept=text/xml

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

https://api.elsevier.com/content/article/PII:014067369192310X?httpAccept=text/plain

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

338

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

8781

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1501-1504

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Low dose cyclosporin A therapy in chronic posterior uveitis

2

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Leucocyte movement and colchicine treatment in Behcet's disease

3

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

6

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

7

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation

8

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Cyclosporin A in the treatment of severe Behçet's uveitis.

10

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Chlorambucil in Behçet's disease. A reappraisal

11

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Effectiveness of cyclosporin therapy for Behçet's disease

12

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

A controlled trial of azathioprine in Behçet's syndrome

13

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

S antigen-induced experimental autoimmune uveo-retinitis in rats

14

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat

15

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Anti-Ia antibody diminishes ocular inflammation in experimental autoimmune uveitis

17

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Prevention of experimental autoimmune uveoretinitis by active immunization with autoantigen-specific monoclonal antibodies.

18

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis

21

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Induction of tolerance in peripheral T cells with monoclonal antibodies.

23

1 reference

10.1016/0140-6736(91)92310-X

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Identifiers

10.1016/0140-6736(91)92310-X

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36535110&oldid=1759864881"